SCHEMBL7688028

SCHEMBL7688028

CCCCCCCCC(C)(C(=O)O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GGPS1 O95749 1/20 0.50
CES2 O00748 1/20 0.47
GPR84 Q9NQS5 7/20 0.46
PPARG P37231 7/20 0.46
PPARD Q03181 7/20 0.46
PPARA Q07869 7/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
PTPN1 P18031 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
MEN1 O00255 1/20 0.46
ESR1 P03372 1/20 0.46
ALOX15 P16050 1/20 0.46
PDE4A P27815 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28423411 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL7570807 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL338276 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL337569 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL10339977 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL9153322 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL5859353 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL13687266 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL9500045 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL338120 1.00 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113372691-A Resin composition, reinforcing liquid, reinforcing layer, and optical protective film 宁波长阳科技股份有限公司 2021-09-10 CN disclosed
US-6384279-B1 OXIDIZING A DIAMIDODIOL TO FORM A DIACID FOLLOWED BY COUPLING WITH AN ARYL DIAMINE THE CLOROX COMPANY 2002-05-07 US disclosed
US-20020028970-A1 SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL THE CLOROX COMPANY 2002-03-07 US disclosed
US-6297400-B1 CHELATING AGENTS FOR IMPROVED WASHFASTNESS OF DYE WHEN IN A BLEACHING ENVIRONMENT THE CLOROX COMPANY 2001-10-02 US disclosed
WO-2001002343-A1 IMPROVED SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL THE CLOROX COMPANY (US) 2001-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028970-A1 SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL DDT, DDC, MLYCD GGPS1 2284/4885CES2 3273/4885GPR84 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.